[The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases].

Alonso-Navarro, Hortensia

[The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases]. [electronic resource] - Medicina clinica May 2006 - 697-706 p. digital

Publication Type: Journal Article; Review

0025-7753

10.1157/13088772 doi


Aryl Hydrocarbon Hydroxylases--genetics
Cytochrome P-450 CYP2C19
Drug-Related Side Effects and Adverse Reactions
Genetic Predisposition to Disease
Humans
Mixed Function Oxygenases--genetics
Pharmacogenetics
Polymorphism, Genetic